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Abstract
Microbial biofilms are composed of a hydrated matrix of biopolymers including polypeptides, polysaccharides and nucleic
acids and act as a protective barrier and microenvironment for the inhabiting microbes. While studying marine biofilms, we
observed that supernatant produced by a marine isolate of Bacillus licheniformis was capable of dispersing bacterial
biofilms. We investigated the source of this activity and identified the active compound as an extracellular DNase (NucB). We
have shown that this enzyme rapidly breaks up the biofilms of both Gram-positive and Gram-negative bacteria. We
demonstrate that bacteria can use secreted nucleases as an elegant strategy to disperse established biofilms and to prevent
de novo formation of biofilms of competitors. DNA therefore plays an important dynamic role as a reversible structural
adhesin within the biofilm.
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Introduction
In their natural environment most bacteria grow within surface
attached communities known as biofilms. Bacterial biofilms are
problematic in industrial settings, where they contribute to
biofouling [1] and in human health, where they contribute
directly to antibiotic resistant infections [2,3]. Biofilms consist of
sessile bacteria embedded within a hydrated extracellular matrix,
with a physiology, gene expression pattern and morphology that is
distinct from planktonic cells [4,5,6].
The extracellular matrix contains a complex arrangement of
extracellular polysaccharides and proteins as well as considerable
quantities of extracellular DNA or eDNA [7]. The first
observation of eDNA as a structural component in biofilms was
by Catlin in 1956 [8] where he demonstrated not only that DNA
could be isolated from the matrix itself but, in an elegant
experiment, showed that the addition of bovine DNaseI
significantly reduced the viscosity of bacterial biofilms, ultimately
leading to dispersal. This work was further developed by
Whitchurch [9] who showed that DNA is involved in the initial
steps of adhesion and biofilm formation, and that bovine DNaseI
inhibits biofilm formation for up to 60 hours after the biofilm
growth is initiated. This has led to the use of both commercial
bovine and recombinant human DNaseI in the disruption of
medically important biofilms [10]. Treatment of antibiotic
resistant biofilms with DNaseI has been shown to increase matrix
permeability, resulting in a subsequent increase in antibiotic
susceptibility [11].
Bacteria are capable of modifying the structure of their own
biofilms, as part of their lifecycle. This can be carried out by the
secretion of matrix degrading enzymes such as proteases and
polysaccharide degrading enzymes such as amylases or Dispersin
B [7,12]. Furthermore, it has been recently shown that unusually
dense biofilms are produced by a Staphylococcus aureus mutant which
can no longer secrete its main thermonuclease [13]. Here we
demonstrate for the first time that secreted bacterial nucleases can
also be employed to control the development and dispersal of
bacterial biofilms, presumably by degradation of structurally
important nucleic acids.
Materials and Methods
Bacterial strains, media, growth conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. All strains were grown at 37uC under vigorous agitation
in LB medium (VWR, UK) unless specified otherwise.
Strain constructions and transformation
The cloning and transformation procedures were performed
according to established techniques [14] and suppliers’ manuals.
Restriction enzymes, DNA polymerases, DNase I, RNase I, T4
DNA ligase were obtained from Fermentas Life Sciences (Vilnius,
Lithuania) and used as specified by the suppliers. Deoxynucleotide
primers for PCR were obtained from Invitrogen (UK), and Table 2
lists the sequences of primers used.
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licheniformis EI-34-6
B. licheniformis EI-34-6 was grown in 10 ml Air Membrane
Surface (AMS) bioreactors as described previously [15] in NGF
medium (Nutrient broth (Oxoid) 13 g/l, 1% glycerol, 1 mM
FeCl2). After 7 days of growth, the medium underneath the filter
membranes was collected, pooled, centrifuged at 7800 rpm in
50 ml falcon tubes for 10 min and filtered using a 0.2 mm syringe
filter to ensure sterility.
Biofilm formation inhibition and dispersal screening
method
Biofilm dispersal was screened using clear 96 well flat bottom
polystyrene tissue culture plates (BD-Falcon, USA). Bacillus
licheniformis DSM13 and other bacterial strains tested were grown
for 48–96 h and diluted 1:100 in fresh LB. 200 ml of this culture
was added to every well of a 96 well plate. To test for inhibition of
biofilm formation, the biofilm dispersal compound was added
directly, and the plate was incubated at 37uC, without shaking, for
20–28 h to allow for biofilm development. To test for dispersal
activity, the biofilm dispersal compounds were added in varying
concentrations after 20–28 h of growth and biofilm development
at 37uC, and the plate was further incubated for 1 h at 37uC.
Then all non-attached cells were removed by discarding the
culture medium and rinsing the plate in a container by immersing
and agitating gently four times in tap water. Attached biofilm
material was stained by addition of 250 ml of 0.5% crystal violet
solution (CV) to each well of the plate for 10 min. Unbound CV
stain was removed by aspiration and the plate was rinsed again in
tap water until no more CV was observed to dissolve in the water.
The plates were air dried and photographed. Subsequently, 250 ml
of 96% ethanol containing 2% acetic acid (v/v) was added to each
well. Adsorption at 595 nm was measured using a Fluostar
Optima plate reader (BMG Labtech, UK), and the data was
analysed using the MARS software package (BMG Labtech, UK)
and Microsoft Excel.
Isolation and Bioassay guided fractionation of proteins
from the supernatant
The proteins in the AMS supernatant were concentrated 50 fold
by precipitation with trichloroacetic acid (TCA) (Sigma, UK) as
follows: The supernatant of several AMS cultures was pooled, and
6.1 M TCA solution was added to give a final concentration of
0.9 M TCA. This solution was kept on ice for 30 minutes to allow
for protein precipitation and the precipitated protein was collected
through centrifugation (10 min at 7800 rpm in 50 ml falcon
tubes). The protein containing pellets were washed twice using ice
cold 96% ethanol, and air dried for 30 min at 45uC. Each pellet
was dissolved in 1:50
th of the original volume with 0.05 M Tris-
HCl buffer (pH 7.0). This concentrate was fractionated using a
Superose
TM 12 (GE Healthcare, UK) gel filtration column (height
40 cm, diameter 3 cm) using ultra pure water as the mobile phase
and fractions of 12 ml each were collected. The fractions were
tested for biofilm dispersal activity using the 96 well microtitre
plate setup, with crude supernatant as the positive control and
H2O as the negative control. Proteins in the active fraction were
concentrated again via TCA precipitation (as before) and analysed
by SDS page.
SDS-page and peptide mass fingerprinting
The single active fraction from gel filtration on Superose
TM 12
was concentrated 106via TCA precipitation in 2 ml micro-tubes
and separated on a 4–12% Tris-Tricine gel using MES buffer
(Invitrogen, UK). A Novex Sharp Pre-stained protein standard
(Invitrogen, UK) was also loaded to determine protein size. After
electrophoresis the gel was stained using Biosafe Coomassie
(Biorad, UK) according to the manufacturer’s protocol. Three
bands were visible on the gel, one abundant band at 12 kDa and
two higher bands around 30 and 34 kDa. These three bands were
Table 1. Strains and Plasmids used.
Strains Genotype Source/Reference
B. licheniformis EI-34-6 Environmental isolate [15]
B. licheniformis DSM13 Sequenced type strain http://www.bgsc.org/
B. subtilis NZ8900 trpC2, amyE::spaRK;K m
R [17]
B. subtilis ATCC6633 Subtilin producer [30]
E. coli DH5alpha Invitrogen
Plasmids Characteristics and description Reference
pNZ8901 Cm
R, shuttle vector, SpaS promoter [17]
pNZ8902 Ery
R, shuttle vector, SpaS promoter [17]
pNZ8901-nucB Cm
R, B. licheniformis EI-34-6 nucB cds This work
pNZ8902-nucB Ery
R, B. licheniformis EI-34-6 nucB cds This work
pNZ8901-Barnase Cm
R, B. licheniformis EI-34-6 barnase cds This work
pNZ8901-Barnase-Barstar Cm
R, B. licheniformis EI-34-6 barnase and barstar containing cds. This work
Km
R: Kanamycin resistance, CmR: Chloramphenicol resistance, Ery
R: Erythromycin resistance. cds: Coding sequence.
doi:10.1371/journal.pone.0015668.t001
Table 2. Primers used in this study.
nucB-fw+BsteII ATAGGTGACCGTCATGATCAAAAAATGGGCGGTTCATCTGC
nucB-rv+XbaI ATCTCTAGATATTTGTTTTTCGCCTTTTATTG
Barnase-fw+BstEII ATAGGTGACCTCCATGAAAAAAATATTATCAACTC
Barnase-rv+hindIII CTAGAAGCTTCATATGATCATCTCATTCTCGTAAAC
barstar-RV_HindIII GTAGAAGCTTGAAGCGCCCGCTCGTTTTCTGTT
(Restriction sites are underlined).
doi:10.1371/journal.pone.0015668.t002
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Proteome Analysis Facility (www.nepaf.com), Newcastle, UK).
The peptide fragments were analysed against NCBI NC_
006270.faa 2008.04.22 (Bacillus_licheniformis_ATCC_14580),
NCBI NC_006322.faa 2008.04.22 (Bacillus_licheniformis_DSM
_13), NCBI C_000964.faa 2008.04.22 (Bacillus_subtilis) and the
common Repository for Adventitious Proteins.
Cloning and overexpression of NucB and Barnase in
Bacillus subtilis NZ8900
Primers were designed to amplify both identified nuclease genes
based on the published genome sequence of B. licheniformis DSM13
[16].
For barnase, primer sets were designed to amplify the gene only
and also the barnase-barstar operon. PCR was performed using
Phusion DNA polymerase (Finnzymes, Finland). Table 2 lists the
nucleotide sequences of the primers used. The barnase gene and
barnase-barstar operon were successfully amplified in one.
The PCR reaction to amplify nucB did result in several amplified
fragments, and a faint band of the correct size was present. This
band was isolated from the agarose gel (gel isolation kit,
Invitrogen, UK) and used as a template for a new PCR. The
amplified genes were digested with Eco91I, XbaI (nucB) and Eco91I,
HindIII (barnase, barnase-barstar) and ligated into vectors pNZ8901
(Cm
R) and pNZ8902 (Ery
R). The ligation mixture was trans-
formed to E. coli DH5 alpha. Colonies were screened using colony
PCR with the unique primers mentioned above and plasmids were
isolated from positive clones. Plasmids were analysed by restriction
and correct plasmids were sequenced. Constructed plasmids are
listed in Table 1. The constructed plasmids were transformed to
Bacillus subtilis NZ8900 [17] using natural competence [18].
B. subtilis NZ8900+pNZ8901/2-nucB clones were screened on
DNase test agar containing methyl Green (Oxoid, UK) as follows.
A colony was streaked onto the DNase test agar and grown
overnight at 30uC. Subsequently a drop of B. subtilis ATCC6633
culture supernatant containing subtilin and 1% agar was spotted
next to the colony. The plates were further incubated for 2 h at
37uC and colonies developing a halo due to the degradation of
DNA were judged positive. Correct B. subtilis clones containing the
Barnase gene were characterized by colony-PCR followed by
plasmid isolation and restriction analysis of the obtained plasmid.
Correct clones were picked from single colonies and transferred
to a shake flask containing LB and the appropriate antibiotics
(Kanamycin and Chloramphenicol/Erythromicin). At an OD600
of ,1.0, 5% cell free supernatant of an overnight B. subtilis
ATCC6633 culture was added to provide subtilin to induce
expression and the total culture supernatant was harvested 2 h
after induction.
Overproduction of the NucB or Barnase was visualised on SDS-
page after 106 concentration via TCA precipitation. The
concentration of overproduced NucB was estimated on SDS-page
by comparing band intensity after staining the gel with Bio-Safe
Coomassie (Biorad) against a BSA standard. When production of
Barnase was induced the culture stopped growing and no
overproduction of Barnase could be detected on a Coomassie
stained PAA gel. To circumvent this problem the gene
downstream of Barnase, barstar, was also included in the
overexpression construct. This strategy yielded an improvement
in Barnase overexpression.
Testing of active fractions for DNase activity
DNase activity was tested by incubating purified plasmid DNA
with the DNase containing fractions for 30 min at 37uC. The
samples were run on a 1% agarose gel containing ethidium
bromide to visualize DNA degradation.
Results
It has been shown previously that a marine isolate of Bacillus
licheniformis, strain EI-34-6, produces the antibiotic bacitracin along
side a red pigment when growing in an air-membrane surface
(AMS) bioreactor, whereas this is not observed in standard
planktonic growth in shakeflasks [13]. The supernatant from
cultures grown in these biofilm conditions, but not during standard
shakeflask growth, was observed to inhibit both biofilm formation
and to disperse bacterial biofilms. Inhibition of formation and
dispersal of the biofilms of both Gram-positive and Gram-negative
bacteria including B. licheniformis, B. subtilis, Escherichia coli,
Micrococcus luteus and Pseudomonas was observed in a standard
biofilm dispersal assay using a 96 well plate format crystal violet
staining, selected examples are shown in Fig. 1. Dispersal of
existing biofilms was rapid and partial dispersal was visible within
2.5 min. At higher concentrations, dispersal was complete within
12 minutes (Fig. 2).
To identify the component of the supernatant responsible for
biofilm dispersal activity, the supernatant of strain B. licheniformis
EI-34-6 (grown for 7 days in an AMS bioreactor) was subjected to
bioassay guided fractionation. We tested multiple methods of
concentrating the supernatant (rotary evaporation, freeze drying,
TCA precipitation) and multiple gel filtration media (Sephadex
TM
G-50, Sephadex
TM LH-20, Superose
TM 12, GE Healthcare, UK).
The best separation of the active fraction was achieved using TCA
Figure 1. Dispersal of several bacterial species by AMS supernatant. Typical examples of dispersal of several 26 hour grown biofilm forming
strains by AMS supernatant. Remaining biofilm visualised by CV staining after 30 minutes incubation with dispersal compound. x=control (only
medium added), 10%=10% of AMS supernatant added, 5%=5% of AMS supernatant added.
doi:10.1371/journal.pone.0015668.g001
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TM 12 gel
filtration. Proteins in the active fraction were concentrated by
TCA precipitation again and analysed by SDS page giving three
distinct protein bands (Fig. 3).
Identification of proteins in the active fraction by peptide
mass fingerprinting
Proteins in the active fraction were identified by SDS-page and
peptide mass fingerprinting. The lowest molecular weight band on
the SDS-page gel, approx 12 kDa, contained two small proteins,
both of them nucleases. The most abundant protein was Barnase
(locus_tag: BL03601), a secreted ribonuclease, and the other
protein was NucB (locus_tag: BL00126), a secreted deoxyribonu-
clease. The second band, cut out at approximately 30 kDa,
contained three different proteins. The most abundant protein was
protein YckK (locus_tag: BL01829) from the solute-binding
family. Also present was the glycine betaine ABC transporter
(opuAC; locus_tag: ‘‘BL01556’’) and the ribonuclease present in
the 12 kDa band. The third band, cut out at approximately
36 kDa, contained three different proteins. The most abundant
protein was the same glycine betaine ABC transporter found in the
30 kDa band. Also present was an ABC transport system
substrate-binding protein and probably also the putative extracel-
lular solute-binding protein YckB (locus_tag: BL01818). We tested
the correlation between biofilm dispersal activity and DNase
activity and found that all culture media and fractions capable of
dispersing biofilms also contained DNase activity (data not shown).
Based on these results the two most likely candidates to have
biofilm dispersal activity, the predicted ribonuclease Barnase and
the predicted deoxyribonuclease NucB, were cloned.
Overexpression of NucB and Barnase
Cloning and overexpression of NucB and Barnase was
performed in Bacillus subtilis NZ8900. Primers were designed to
amplify both identified nuclease genes based on the published
genome sequence of B. licheniformis DSM13 [16]. Both genes were
successfully amplified from B. licheniformis EI-34-6 chromosomal
DNA and cloned into the SURE expression vectors pNZ8901 and
pNZ8902 using E. coli as an intermediate host. Both vectors were
transformed to the SURE expression strain B. subtilis NZ8900
[17]. Direct over-expression of NucB was successful with
expression being under the control of pSpaS induced by subtilin
(Fig. 4), whilst over-expression of Barnase required the inclusion of
the gene downstream of Barnase, Barstar. Barstar is known to
inhibit the intracellular RNase activity of the pre-barnase [19],
thus allowing the over-expression and secretion of the Barnase
itself, although on a lower level than for NucB.
The supernatant of B. subtilis NZ8900 containing the induced
overexpression construct of NucB had strong DNase activity (data
not shown) and was capable of dispersing established biofilms,
whereas a control with an induced empty vector was not. The
non-purified supernatant could disperse biofilms at NucB
concentrations as low as 3 ng/ml (Fig. 5).
Figure 2. Dispersal efficiency in time and concentration.
Efficiency of dispersal of B. licheniformis DSM13 24 hour old biofilm
by AMS supernatant (sup.) visualised as remaining CV stain as measured
by plate reader. Incubation time in minutes (’) and seconds (’’) indicated
on the left, concentration of AMS supernatant indicated on top. The
biofilm remaining is indicated with both a colour scale (dark blue: no
dispersal, white: full dispersal) and as a percentage of non-dispersed
biofilm (red numbers).
doi:10.1371/journal.pone.0015668.g002
Figure 3. Efficiency of different AMS supernatant fractionation
methods. A: total supernatant of the AMS culture; B: active fraction
obtained after rotary evaporation followed by Sephadex G50 gel
filtration; C: active fraction obtained after freeze-drying by Sephadex-
LH20 gel filtration, D+E: Active fraction obtained by TCA precipitation
followed by Superose 12 gel filtration. m=Invitrogen Novex Sharp Pre-
stained Marker, band sizes indicated in kDa. Arrows indicate bands 1, 2
and 3 cut out for peptide mass fingerprinting, as described in text.
doi:10.1371/journal.pone.0015668.g003
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pared to commercially available RNaseI in its ability to disperse
biofilms. No dispersal was observed using either heterologously
produced Barnase or RNaseI in concentrations up to 10%
supernatant/well or 200 units/ml respectively. We also tested the
activity of Barnase in combination with bovine DNaseI or NucB,
but no significant increase in dispersal was found compared to
NucB or DNaseI alone (data not shown).
The B. licheniformis EI-34-6 genes for NucB and Barnase were
sequenced (MWG operon, UK) to identify potential differences
with the known sequenced strain. Both nucB (22bp of
428bp=5.1%) and barnase (21bp of 455bp=4.6%) contained
base pair substitutions, leading to 4 amino acid changes in the
NucB protein and 6 amino acids changes in the Barnase protein,
compared to the DSM13 sequence. The sequences are available
through Genbank, accession numbers HQ112343 (nucB) and
HQ112344 (barnase).
Comparison of NucB and Bovine DNase I biofilm
dispersal ability
Bovine DNaseI gave full dispersal of the bacterial biofilm above
15 ng/ml. At concentrations below 15 ng/ml there was still partial
dispersal, and at the lowest level tested (0.7 ng/ml) ,35% of the
biofilm was dispersed (Fig. 5). For NucB, above 3 ng/ml there was
full biofilm dispersal whilst below this concentration the dispersal
activity dropped rapidly, and at 0.7 ng/ml only 15% of the biofilm
was dispersed. From this experiment it is clear that eukaryotic
DNaseI and bacterial NucB have a very different dose response
curve in relation to biofilm dispersal. Importantly, NucB is fully
dispersing the biofilm at a w/v concentration 5 times lower than
that of DNaseI. (Fig. 5) The defined cut off of activity with NucB,
compared to the more gradual loss of activity of DNaseI, suggests
that the bacterial nuclease is better adapted to disrupt eDNA
present in bacterial biofilms.
Discussion
It has been comprehensively demonstrated that DNA is present
in biofilms [8,9] and that it plays an important structural role in
biofilm architecture [11,13,20,21]. It has also been shown that
some microbial species have significant quantities of RNA present
within the biofilm matrix [22]. Furthermore, it has been observed
that some bacteria, such as P. aeruginosa, have developed regulatory
circuits that can utilize the eDNA present in the biofilm as a
nutrient source during phosphate starvation through expression of
extracellular nucleases [23]. In addition, based on the presence of
eDNA in biofilms, commercially available bovine or human
DNaseI has been used to treat bacterial biofilm infections
[9,11,21].
Figure 4. Heterologous overexpression of NucB in B. subtilis
NZ8900. Lane m=Invitrogen Novex Sharp Pre-stained Marker, band
sizes indicated in kDa. Lanes A–C: 20 fold concentrated TCA
precipitated supernatant of strain B. subtilis NZ8900+pNZ8901-nucB,
loaded 20 ml( A), 10 ml( B), 5 ml( C). Lane D: loaded 20 ml unprocessed
supernatant. Arrow indicates NucB position.
doi:10.1371/journal.pone.0015668.g004
Figure 5. Comparison between NucB and DNaseI mediated
biofilm dispersal. Efficiency of dispersal of 24 hour old B. licheniformis
DSM13 biofilms by the tested nucleases in decreasing concentrations.
Dispersal of the target biofilm was determined using a 96 well
microtitre plate setup, using a concentration range of either B. subtilis
supernatant containing NucB or commercially available DNaseI. For
every data point, the average of at least 6 independent wells was taken,
and the experiment was repeated three times.
doi:10.1371/journal.pone.0015668.g005
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employ endogenously-derived nucleases in order to influence the
biofilm in which they naturally grow. Bacteria have evolved a neat
solution to escape their own biofilms and appear to use the same
approach to disperse biofilms of competing species in a controlled
and precise manner. Uniquely, we set out to identify the observed
dispersal activity of a bacterial culture supernatant against
competing species [24]. As a result of this, we have shown that
bacteria use secreted nucleases as an elegant strategy to prevent de
novo biofilm formation and that these nucleases can also to be used
to disperse established biofilms of both Gram positive and Gram
negative bacteria.
We observed that during biofilm growth B. licheniformis secretes
both a ribonuclease and a deoxyribonuclease. We demonstrated
that the deoxyribonuclease NucB is sufficient for dispersal of
several target biofilms. Despite the observation of a ribonuclease
(Barnase) within active supernatant we did not observe an
additional effect of the ribonuclease on dispersal efficacy in vitro.
However, it is tempting to speculate that in vivo, the Barnase does
have an important role. As already observed by Catlin in 1954, the
addition of RNase could improve the efficiency of the DNase in
degrading eDNA, which lead him to conclude some biofilms may
contain a DNase inhibitor and that ‘‘this DNase inhibitor is a
ribonucleic acid’’ [8]. Although not observed our experimental
setup, a possible reason for the expression of Barnase and NucB
together could be found in the inhibitory effect of RNA on DNase
activity.
In Bacillus subtilis, a close relative of B. licheniformis, NucB
expression was studied in detail and found to be controlled by a
sporulation specific promoter [25]. We suggest that the DNase
activity of NucB leads to biofilm dispersal or permeabilization
during sporulation, allowing spores to more readily disperse from
the biofilm into the wider environment. It is also tempting to
speculate that B. licheniformis uses extracellular DNases in order to
disrupt biofilms of competing bacteria as a method of competing
for resources. Combined with the expression of bacitracin during
the same mode of growth B. licheniformis appears to use an elegant
multi-approach strategy against competing species, breaking up
their biofilms and secreting antibiotics at the same time.
The viscoelastic and adhesion properties of biofilms have been
examined, however to date, work has mainly focused on the
influence of polysaccharides on the physical properties of the
matrix [26,27]. Linear high molecular weight DNA is known to
lead to an increase in viscosity of aqueous solutions [28], thus
eDNA is likely to contribute to the viscoelastic and adhesion
properties of the biofilm matrix. The release of a nuclease would
therefore represent an elegant solution which might allows cells to
escape from a ‘‘sticky’’ eDNA matrix such as those present in
biofilms. The use of DNA to ‘‘trap’’ bacterial cells is also observed
in the eukaryotic immune response, where lysis of neutrophils can
create neutrophil extracellular traps, or NETs, which contain large
amounts of eDNA. These are thought to play an important role in
capturing invasive pathogens [29]. The existence, therefore of
nuclease activity may also allow bacteria to escape from such traps.
Our observations are also supported by work with Staphylococcus
aureus. The amount of eDNA released into the biofilm matrix and
the activity of secreted Staphylococcal nucleases also influences
biofilm structure [13]. Thus, the use of eDNA and nuclease to
control of biofilm architecture does seem to be a strategy adopted
by several groups of bacteria.
It is increasingly apparent that DNA is used both by bacteria
and eukaryotes as a structurally important adhesin. We show here
that the release of a matching nuclease represents an effective anti-
adhesin strategy, and the combination of both mechanisms brings
about a very elegant method allowing considerable fine-tuning of
the system. It is clear that the function of DNA goes beyond its role
as a carrier of genetic information alone but, in the form of eDNA,
is a key component to control the dynamic building, reshaping and
destruction of microbial biofilms.
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